← 返回

预防性地塞米松对接受 axicabtagene ciloleucel 患者细胞因子释放综合征与免疫效应细胞相关神经毒性发生率及严重程度影响的单中心分析

英文原题:Single-centre analysis of prophylactic dexamethasone on the incidence and severity of cytokine release syndrome and immune effector cell-associated neurotoxicity in patients receiving axicabtagene ciloleucel.

查看英文原题

Single-centre analysis of prophylactic dexamethasone on the incidence and severity of cytokine release syndrome and immune effector cell-associated neurotoxicity in patients receiving axicabtagene ciloleucel.

PubMed 2026/01/19(内容时间) Br J Haematol Q2 · IF 3.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

摘要

这条来源本身就没有摘要(PubMed 未提供),不是「还没翻译」。可以点最下面的「在 PubMed 查看」打开原文献页面。

论文信息

作者
Schrum DP、Eberwein E、Cheng S、Feng A、Kennedy E、Choi T、Huggins J、Kang Y
第一作者单位
Department of Pharmacy, Duke University Medical Center, Durham, North Carolina, USA.United States
通讯作者单位
Division of Hematologic Malignancies and Cellular Therapies, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.United States
期刊
British journal of haematology2026 Apr
原文标识
PubMed 41555654 · DOI 10.1111/bjh.70343